Home » Adar Poonawalla of Serum Institute gets ‘Y’ category protection

Adar Poonawalla of Serum Institute gets ‘Y’ category protection

Sharing is Important
  •  
  •  
  •  
  •  
  •  
  •  
  •  

The government has decided to give security of ‘Y category’ to Adar Poonawalla, Chief Executive Officer of Serum Institute of India.

The Central Industrial Security Force will provide security to them in view of the possibility of danger on them.

His company is producing the covishield vaccine in India.

ALSO READ: A Viral Image That Became A Symbol Of The Devastation Caused By Covid In India

According to news agency PTI, Prakash Kumar Singh, Director, Government and Regulatory Affairs of Serum Institute of India, wrote a letter to Home Minister Amit Shah on 16 April demanding protection of Adar Poonawalla.

The centre’s decision has come after Director, Government and Regulatory Affairs at Pune-based Serum Institute, Prakash Kumar Singh had written to Union Home Minister Amit Shah on April 16 requesting security for Poonawalla.

READ:  Helping India and Pakistan to negotiate: confirms UAE

In this letter, Singh had stated that Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies.

ALSO READ: 20-30% Covid-19 infected people lose natural immunity against infection in 6 months: Study

In this letter, Singh also said, “We are working shoulder to shoulder to fight against COVID-19 pandemic with the Government of India under the dynamic leadership of Prime Minister Narendra Modi Ji.”

Covishield, one of the two COVID-19 vaccines used in India’s COVID-19 vaccination programme, is being manufactured by SII.

Serum Institute has decided to cut the price of coviciled vaccine. Serum Institute of India has decided to cut the price of coviciled vaccine.

READ:  Serum Sets Covishield Price For States, Private Hospitals

ALSO READ: Hospitals Overwhelmed, Graveyards Overflowing As Covid-19 Infections Surge In India

The company’s CEO Adar Poonawalla gave this information. Announcing this on Twitter, he said, “As a philanthropic move by the Serum Institute of India, I reduce the price of one dose from Rs. 400 to Rs. 300 for the state governments.

This will give the state governments a thousand crores of rupees.” Will be saved and vaccine can be given to more and more people. And countless lives can be saved.”

You can connect with Ground Report on FacebookTwitter and Whatsapp, and mail us at GReport2018@gmail.com to send us your suggestions and writeups

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.